Literature DB >> 29705292

EphA2 Transmembrane Domain Is Uniquely Required for Keratinocyte Migration by Regulating Ephrin-A1 Levels.

Rosa Ventrella1, Nihal Kaplan1, Paul Hoover1, Bethany E Perez White1, Robert M Lavker1, Spiro Getsios2.   

Abstract

EphA2 receptor tyrosine kinase is activated by ephrin-A1 ligand, which harbors a glycosylphosphatidylinositol anchor that enhances lipid raft localization. Although EphA2 and ephrin-A1 modulate keratinocyte migration and differentiation, the ability of this cell-cell communication complex to localize to different membrane regions in keratinocytes remains unknown. Using a combination of biochemical and imaging approaches, we provide evidence that ephrin-A1 and a ligand-activated form of EphA2 partition outside of lipid raft domains in response to calcium-mediated cell-cell contact stabilization in normal human epidermal keratinocytes. EphA2 transmembrane domain swapping with a shorter and molecularly distinct transmembrane domain of EphA1 resulted in decreased localization of this receptor tyrosine kinase at cell-cell junctions and increased expression of ephrin-A1, which is a negative regulator of keratinocyte migration. Accordingly, altered EphA2 membrane distribution at cell-cell contacts limited the ability of keratinocytes to seal linear scratch wounds in vitro in an ephrin-A1-dependent manner. Collectively, these studies highlight a key role for the EphA2 transmembrane domain in receptor-ligand membrane distribution at cell-cell contacts that modulates ephrin-A1 levels to allow for efficient keratinocyte migration with relevance for cutaneous wound healing.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29705292      PMCID: PMC6398600          DOI: 10.1016/j.jid.2018.04.011

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  58 in total

1.  Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion.

Authors:  A Davy; N W Gale; E W Murray; R A Klinghoffer; P Soriano; C Feuerstein; S M Robbins
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

Review 2.  Lipid rafts and membrane dynamics.

Authors:  Lawrence Rajendran; Kai Simons
Journal:  J Cell Sci       Date:  2005-03-15       Impact factor: 5.285

3.  Lipid rafts and detergent-resistant membranes in epithelial keratinocytes.

Authors:  Kathleen P McGuinn; Mỹ G Mahoney
Journal:  Methods Mol Biol       Date:  2014

Review 4.  Conformational transitions and interactions underlying the function of membrane embedded receptor protein kinases.

Authors:  Eduard V Bocharov; Georgy V Sharonov; Olga V Bocharova; Konstantin V Pavlov
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-25       Impact factor: 3.747

5.  HB-EGF synthesis and release induced by cholesterol depletion of human epidermal keratinocytes is controlled by extracellular ATP and involves both p38 and ERK1/2 signaling pathways.

Authors:  Séverine Giltaire; Sylviane Lambert; Yves Poumay
Journal:  J Cell Physiol       Date:  2011-06       Impact factor: 6.384

6.  EphA2 proteomics in human keratinocytes reveals a novel association with afadin and epidermal tight junctions.

Authors:  Bethany E Perez White; Rosa Ventrella; Nihal Kaplan; Calvin J Cable; Paul M Thomas; Spiro Getsios
Journal:  J Cell Sci       Date:  2016-11-04       Impact factor: 5.285

Review 7.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

8.  Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38.

Authors:  Ralph Jans; Ganka Atanasova; Michel Jadot; Yves Poumay
Journal:  J Invest Dermatol       Date:  2004-09       Impact factor: 8.551

9.  EphA2/Ephrin-A1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM10 Regulation of EGFR Signaling.

Authors:  Nihal Kaplan; Rosa Ventrella; Han Peng; Sonali Pal-Ghosh; Constadina Arvanitis; Joshua Z Rappoport; Brian J Mitchell; Mary Ann Stepp; Robert M Lavker; Spiro Getsios
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

Review 10.  Lipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and Cancer.

Authors:  Toshiyuki Murai
Journal:  Front Immunol       Date:  2015-08-20       Impact factor: 7.561

View more
  5 in total

Review 1.  Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis.

Authors:  Brian Wu; Jason S Rockel; David Lagares; Mohit Kapoor
Journal:  Curr Rheumatol Rep       Date:  2019-04-12       Impact factor: 4.592

2.  EphA2 signaling within integrin adhesions regulates fibrillar adhesion elongation and fibronectin deposition.

Authors:  Alexandra C Finney; Matthew L Scott; Kaylea A Reeves; Dongdong Wang; Mabruka Alfaidi; Jake C Schwartz; Connor M Chitmon; Christina H Acosta; James M Murphy; J Steven Alexander; Christopher B Pattillo; Ssang-Taek Lim; A Wayne Orr
Journal:  Matrix Biol       Date:  2021-09-17       Impact factor: 10.447

3.  Eph signaling is regulated by miRNA-210: Implications for corneal epithelial repair.

Authors:  Nihal Kaplan; Min Liu; Junyi Wang; Wending Yang; Elaina Fiolek; Han Peng; Robert M Lavker
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

4.  Ciliogenesis and autophagy are coordinately regulated by EphA2 in the cornea to maintain proper epithelial architecture.

Authors:  Nihal Kaplan; Sijia Wang; Junyi Wang; Wending Yang; Rosa Ventrella; Ahmed Majekodunmi; Bethany E Perez White; Spiro Getsios; Brian J Mitchell; Han Peng; Robert M Lavker
Journal:  Ocul Surf       Date:  2021-06-11       Impact factor: 5.033

5.  Extracellular Vesicles in Diagnosis and Treatment of Pancreatic Cancer: Current State and Future Perspectives.

Authors:  J Spencer Lane; Daniel Von Hoff; Derek Cridebring; Ajay Goel
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.